Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
233.41B | 233.87B | 196.58B | 198.96B | 209.09B | Gross Profit |
73.52B | 68.19B | 60.08B | 55.94B | 60.84B | EBIT |
30.50B | 28.09B | 24.18B | 22.07B | 23.91B | EBITDA |
39.87B | 36.22B | 31.24B | 28.25B | 27.50B | Net Income Common Stockholders |
22.09B | 20.22B | 16.77B | 15.60B | 15.06B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
94.04B | 85.22B | 74.39B | 72.65B | 60.04B | Total Assets |
324.11B | 293.10B | 273.29B | 259.04B | 248.03B | Total Debt |
73.43B | 65.65B | 74.78B | 69.76B | 71.35B | Net Debt |
-20.61B | -19.58B | 398.00M | -2.89B | 11.32B | Total Liabilities |
158.79B | 148.02B | 145.61B | 137.07B | 141.63B | Stockholders Equity |
162.16B | 142.52B | 126.06B | 120.59B | 104.95B |
Cash Flow | Free Cash Flow | |||
7.86B | 23.48B | 7.09B | 17.84B | 22.86B | Operating Cash Flow |
25.73B | 34.15B | 24.95B | 27.25B | 30.67B | Investing Cash Flow |
-20.77B | -10.70B | -17.82B | -10.36B | -8.31B | Financing Cash Flow |
3.03B | -12.95B | -5.96B | -4.87B | -9.34B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥194.65B | 7.56 | 2.81% | 3.50% | 26.66% | ||
73 Outperform | $4.04T | 20.12 | 6.51% | 2.03% | 0.83% | -6.10% | |
69 Neutral | $2.59T | 14.53 | 8.41% | 1.21% | 5.85% | 3.72% | |
69 Neutral | $539.88B | 8.19 | 12.46% | 3.51% | 23.35% | 46.19% | |
68 Neutral | $3.17T | 16.50 | 8.35% | 1.62% | 16.32% | 43.72% | |
60 Neutral | $2.81B | 11.31 | 0.21% | 8508.38% | 6.19% | -15.39% | |
59 Neutral | €171.35B | 16.46 | 7.84% | 3.09% | -5.31% | 19.66% |